Susquehanna International Group
HELP

Susquehanna International Group’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Susquehanna International Group’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Sell
26,116
-121,809
-82% -$609K ﹤0.01% 12085
2026
Q1 		$710K Sell
147,925
-152,305
-51% -$985K ﹤0.01% 8782
2025
Q4 		$2.46M Buy
300,230
+26,435
+10% +$170K ﹤0.01% 5222
2025
Q3 		$1.61M Buy
273,795
+248,887
+999% +$1.76M ﹤0.01% 6247
2025
Q2 		$209K Buy
+24,908
New +$181K ﹤0.01% 11120
2025
Q1 		– Sell
-82,859
Closed -$717K – 12627
2024
Q4 		$731K Buy
+82,859
New +$841K ﹤0.01% 7723
2023
Q1 		– Sell
-282
Closed -$3.18K – 12687
2022
Q4 		$3.18K Buy
+282
New +$4.65K ﹤0.01% 12097
2022
Q1 		– Sell
-1,288
Closed -$59K – 13123
2021
Q4 		$59K Buy
1,288
+992
+335% +$62.8K ﹤0.01% 12453
2021
Q3 		$25K Buy
+296
New +$25.9K ﹤0.01% 12509

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Susquehanna International Group's HELP Position: Q2 2026 in Review

Susquehanna International Group reduced its Helus Pharma Inc. Common Stock (HELP) stake by 82% in Q2 2026, selling an estimated $609K and leaving 26,116 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #12085.

Susquehanna International Group first reported a position in HELP in Q3 2021 and has held it in 9 quarters since. The position peaked at $2.46M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Susquehanna International Group held 26,116 shares of Helus Pharma Inc. Common Stock worth $173K as of Q2 2026.
  • Susquehanna International Group sold 121,809 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $609K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12085 holding.
  • Susquehanna International Group first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 9 quarters since.
  • Susquehanna International Group's Helus Pharma Inc. Common Stock position peaked at $2.46M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.